Thank you for submitting your manuscript for consideration by The EMBO Journal. After some delay due to difficulties with the availability of referees during the past Christmas holiday period, three referees have now evaluated it and their comments are shown below. Please note that referee 3 decided to sign his report.
As you will see, while referees 1 and 3 are very positive about the paper, referee 2 thinks that at present the scope is too limited that he/she can support its publication here. On balance, and given the very positive vote by the other referees, we will be happy to look at a revised version of the manuscript in which you need to address the referees' comments in an adequate manner and to their full satisfaction. I should add that it is EMBO Journal policy to allow only a single round of revision, and acceptance of your manuscript will therefore depend on the completeness of your responses in this revised version.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Peer Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html
We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may preparation contains before mixing with SUVs. For a good comparison, we need representative images of GUV/SUV mixtures with and without Cplx (Fig 2 panel c only has with Cplx) and probably also a GUV preparation prior to mixing with SUVs. Finally, can it be (roughly) estimated how much the fusion of docked SUVs contribute to the total fusion observed in the plate reader assay? One additional experiment that would have been great as a further characterization of the role of Cplx and Syt1 in arresting fusion at the docked state (and adding to the current intense debate of what the docked state is), would be to test if the same arrays of docked SUVs exist using SUVs lacking synaptobrevin (i.e., with only Syt1 and in the presence of Cplx). This might be beyond the scope of the current paper.
2-Statistical significance. As in other liposome studies, the authors spend little efforts in testing statistical significance of observed differences. The manuscript indicates that experiments were repeated 3-4 time 'with very similar results' but it is not clear how similar and the typical examples shown in the figures already reveal a considerable amount of variation (for instance comparing the Ca2+-independent release under identical conditions in the first 5 min of the assay, which appears to be twice as high in Fig 3  as compared to Fig 1) . There might be a tradition not to quantify and perform statistical tests, but this needs to change to substantiate some of the claims in this paper.
Minor issues: -Introduction is slightly too long/verbose. Can be trimmed substantially. Also in Results some experimental details can be moved to Experimental Procedures to optimize the flow.
-When addressing the role of PIP2, especially in the discussion, the recent paper by the Chapman lab in JCB should be mentioned. -In the legend in Fig 3, the black line should be green
Referee #2
This paper uses an elegant in vitro liposome fusion assay to analyze the role of complexin in synaptotagmin triggered fusion. There are many interesting findings in this paper, but its biggest problem is its scope. The paper is limited to in vitro fusion assays of liposomes containing reconstituted proteins without any biochemistry, and there are relatively few experiments. I think that the paper may be acceptable for publication in EMBO J after complementary studies, but at present the data are not completely convincing.
1. The title is inappropriate. It suggests that this paper studies synapses and neurotransmitter release whereas in truth the paper examines liposome fusion in vitro. There is no evidence that the fusion reaction studied here precisely corresponds to synchronous release, and the so-called docked vesicle constitute the readily releasable pool except for the correlation with previous studies with mouse mutants of the same proteins examined here.
2. The paper makes conclusions about docking that as far as I could see are based on a single EM figure containing a few datapoints. I don't see how the authors can come to the conclusion that docking is dependent on synaptotagmin in their system, and that docking and the readily releasable pool are equivalent.
3. The paper uses several synaptotagmin mutants without looking at their biochemical effects in their system. What actually binds to what under their experimental conditions, and how does this change as a function of calcium?
4. The time resolution of the experiments is too low to allow conclusions about how similar the speed of the fusion reaction is to that observed in vivo. Moreover like all currently avalailable in vitro fusion systems the calcium dependence of in vitro fusion indicates a much lower calcium affinity than synaptic vesicle fusion in vitro.
There are many interesting data in this paper, and the authors should be commended for developing an in vitro fusion system that is potentially a significant improvement over existing systems.
However, as it is this paper is rather thin in terms of data, and the conclusions are not completely based on the data that are there.
Referee #3
This is a really interesting paper that endeavors to reproduce some key aspects of Ca2+-triggered synaptic vesicle fusion in a reconstituted system using small unilamellar vesicles (SUVs) containing the v-SNARE synaptobrevin and the Ca2+ sensor synaptotagmin-1, and giant unilamellar vesicles (GUVs) containing the t-SNAREs syntaxin-1 and SNAP-25. Lipid mixing between the SUVs and GUVs as a function of complexin and Ca2+ is studied using a standard fluorescence dequenching assay. The authors find that synaptotagmin-1 enhances lipid mixing both in the absence and presence of Ca2+, and the Ca2+-triggered lipid mixing is very fast for this type of assays. This result is not new, since it has been published by several labs, but what is nice in this paper is that the Ca2+-dependence of the stimulation mirrors that observed for neurotransmitter release in vivo (in other studies the Ca2+ dependence of lipid mixing was not studied, or exhibited some strange features such as a requirement of mM Ca2+ concentrations or a bimodal dependence). But what is particularly interesting in this work, compared to studies in this area using related approaches, is that the authors are able to observe inhibition and stimulation of lipid mixing by complexin, which appears to reproduce at least to some degree the duals roles of complexin in neurotransmitter release. I believe that the paper will be of strong interest to a wide audience and I certainly recommend publication, although I do have some concerns that the authors should address or consider.
1. The main problem with the manuscript is its very strong tone, which I believe it is not justified by the data presented even though I do consider the data very interesting. On one hand, the results do not demonstrate fusion (see point 2) and, on the other hand, the authors emphasize correlations with in vivo data, which is fine, but they do not discuss issues that do not correlate so well. These are some examples: A. The authors claim that their data with the C2B domain Ca2+-binding mutant and the C2B domain polybasic region mutant correlate with the effects of these mutations in vivo; however, it seems to me that the effects of the Ca2+-binding mutant were quite stronger than those of the polybasic region in vivo, whereas the opposite is observed in the lipid mixing assays. The authors should give more quantitative details of the in vivo data and report quantitative similarities or differences with their observations. B. It is true that the authors observe inhibitory and stimulatory effects of complexin in this system, and this correlates qualitatively with in vivo data. However, the proteins they are using are mammalian, and in mammals the stimulatory effect of complexin is quite more substantial than the inhibitory effect, in contrast to what the authors observe in the lipid mixing assays. C. Physiologically, Munc18-1 and Munc13s play crucial roles in neurotransmitter release but they are not present in these assays. D. The authors refer to the deWit 2009 paper to explain that synaptotagmin-1 plays a role in docking, as observed in their assays; however, in the same paper Munc18-1 is also important for docking (an fusion of course), but this is not mentioned. I am not saying that the authors should reproduce all these in vivo observation in their assays, but at least they should acknowledge better the limitations of their study.
2. There is a big tendency in this field to use the term membrane fusion when only lipid mixing is assayed, despite being very well established that the two terms are not equivalent. I would not request that the authors use these terms properly as a condition of publication just because they had the bad luck of having me as a reviewer, but I certainly would like to suggest that the authors try to be as accurate as possible with the language, rather than keep contributing to the confusion we have in this field. More importantly, the fact that the authors do not demonstrate membrane fusion (in the normal sense of lipid and contents mixing without loose of contents) is a main reason why the tone of the paper should be less strong (point 1). Note also in this context that some of the papers they criticize actually tested for contents mixing.
3. The authors also use the cryo-EM data of Figure 2D to claim that they observe fusion, but these data really cannot distinguish between real fusion and bursting of membranes followed by reannealing.
4. The authors should clarify why they count SUV clusters on the GUVs rather than just SUVs on the GUVs to obtain the data of Figure 2B .
5. In the top of page 8, the authors state that control samples treated with neurotoxin did not show any increase in NBD fluorescence, but then they state that the background of these control samples was subtracted. I do not understand why they subtract the background if the increase was zero.
6. In page 10, the authors mention the Ca2+ concentration required for synaptotagmin-1 binding to lipids (from Hui et al., 2005) to correlate with the Ca2+ concentration dependence of their lipid mixing stimulation. However, it would seem more reasonable to compare with the in vivo Ca2+ dependence of neurotransmitter release determined in separate papers by Neher and Sakmann in 2000.
7. I suggest that the authors avoid using the term readily-releasable vesicle pool, since this term is a standard term used in physiology but with a very different meaning to what the authors observe here. Note in this context that the readily-releasable pool is unaffected in synaptotagmin-1 knockout mice. The same issue refers to the term 'synchronized' used in the title; although in this case the term is less misleading, the entire title suggests that this study was performed with physiological studies in vivo, which is clearly not the case.
Josep Rizo
1st Revision -authors' response 27 April 2012
Point by point response to the reviewers' concerns:
Reviewer #1:
1-Quantification of SUVs docked to GUVs. It is not clear why the number of clusters is used as a measure for docking. The number of SUVs per length of membrane seems a better measure.
Clusters were initially used because they provide a very easily identifiable feature for counting. As suggested by the reviewer (and reviewer 3) we have now requantified the data counting instead the number of individual SUVs. The results are the same (see comparison below). We have also included quantification of the total number of SUVs and the % of SUVs which are membrane bound. We have not divided this by GUV surface area, since the 3D surface area is very difficult to assess from the 2D images. Nevertheless the results are consistent between three independent reactions (figure 2 error bars).
old Figure 2B new Figure 2C 
Furthermore, as a control it would be important to test if docked liposomes have the same diameter as free liposomes.
We measured the diameters of free and docked SUVs based on 10 random highmagnification images. There is no difference in diameter within the experimental error quantified. We added the data as Supplementary Figure 4 to the manuscript.
And how many small particles (SUV-size) vesicles, docked or free, the GUV preparation contains before mixing with SUVs. For a good comparison, we need representative images of GUV/SUV mixtures with and without Cpx (Fig 2 panel c only has with Cpx) and probably also a GUV preparation prior to mixing with SUV.
We add an image of a GUV preparation prior to mixing with SUVs (supplementary Figure  3A) . Note that GUV preparations are essentially devoid of any contaminations with the much smaller SUVs. We also add representative cryo-EM pictures of SUV-GUV incubations that were incubated for 5 min at 37°C in the absence or presence of Cpx (supplementary Figure 3B and 3C ). For comparison, total numbers of SUVs docked to the surface of GUVs were counted ( Figure 2C ). Error bars SEM (n=3, for three different EM grids).
Finally, can it be (roughly) estimated how much the fusion of docked SUVs contributes to the total fusion observed in the plate reader assay?
In order to correlate the fusion of docked SUVs observed in the microscope with the dequenching of fluorescence observed in the plate reader assay, we compared the number of input SUVs with the number of docked SUVs before and after the addition of Ca 2+ . About 20% of the input SUVs were already docked to t-SNARE-GUV membranes after an incubation of 1 min at 4°C (new Figure 2D ). This number increased to 80% after a 5 min incubation at 37°C, and, after the addition of Ca 2+ , dropped to 20%. Hence, 60% of the total input SUVs responds with fast kinetics to the addition of Ca 2+ . Correlation of this drop with the corresponding increase of NBD fluorescence derived from plate reader measurements reveals that 10% of the total fluorescence measured in the plate reader assay roughly correspond to 30% of the docked SUV population that fuses with the GUV membrane after the addition of Ca 2+ within 1 min. The quantification results shown in the former Figure 2D (decrease of SUV clusters on GUV membranes in response to Ca 2+ after a preincubation of the SUV-GUV mixture for 1 h on ice (in the presence of CpxII) was replaced by the quantification of the new correlation experiment described above (new Figure 2D) . Fig 3  as compared to Fig 1) . There might be a tradition not to quantify and perform statistical tests, but this needs to change to substantiate some of the claims in this paper.
To demonstrate that the fusion kinetics presented in this paper are highly reproducible, we show for Figure 1 as key figure the kinetics of three additional fusion reactions ( Supplementary  Figure 1 A-C) . The statistical analysis is displayed in Supplementary Figure 1 D , comprising the mean values of the fusion reactions. Error bars SEM (n=4).
We agree that the Ca 2+ independent fusion in the presence of Cpx differs significantly when Figure 1 and 3 are compared. In Figure 3 , the CpxI isoform was used (in all other experiments the CpxII isoform was used). We used the CpxI isoform in order to compare the effect of the truncated CpxI construct, which has been used in the corresponding in vivo studies as closely as possible with the data obtained from the plate reader fusion assay (Xue et al., 2007, Struct Mol Biol) . Indeed, in the assay presented here, CpxI reproducibly has a reduced clamping activity when compared to CpxII, albeit displaying the same overall phenotype as CpxII. The reduced clamping activity of CpxI compared to CpxII might indicate a subtle difference in the function of both isoforms in vivo.
Minor issues:
-Introduction is slightly too long/verbose. Can be trimmed substantially. Also in Results some experimental details can be moved to Experimental Procedures to optimize the flow.
We trimmed down the introduction, but did not remove experimental details from the results section accompanying Figure 1 , because we think that the details described are important to highlight the improvements of this new GUV-SUV fusion assay in comparison to other SUV-only based systems.
-When addressing the role of PIP2, especially in the discussion, the recent paper by the Chapman lab in JCB should be mentioned.
We have now mentioned the results obtained by Wang et al. 2011 in the discussion (when we submitted our manuscript, the paper by Chapman was not published then.)
-In the legend in Fig 3, the black line should be green
Thank you, the corresponding change has been made.
Reviewer 2:
The title is inappropriate. It suggests that this paper studies synapses and neurotransmitter release whereas in truth the paper examines liposome fusion in vitro. There is no evidence that the fusion reaction studied here precisely corresponds to synchronous release, and the so-called docked vesicle constitute the readily releasable pool except for the correlation with previous studies with mouse mutants of the same proteins examined here.
We agree that the terms 'synchronous release' and 'readily releasable pool' are standard terms to describe vesicle exocytosis in living cells using electron microscopy and electrophysiological methods. Since our biochemical in vitro assays may not reproduce the complexity of the underlying mechanism at the neuronal synapse, we have changed the title as follows:' Complexin arrests a pool of docked vesicles for fast Ca 2+ -dependent release'.
The paper makes conclusions about docking that as far as I could see are based on a single EM figure containing a few data points. I don't see how the authors can come to the conclusion that docking is dependent on synaptotagmin in their system, and that docking and the readily releasable pool are equivalent.
The statistical analyses of vesicle docking are based on a cohort of EM pictures and we have extended and modified the procedure as described in the response to reviewer 1 (please also see modified Figure 2 ). In addition, the analyses have been further extended by a biochemical vesicle docking assay, which is described in the next paragraph. As suggested by the reviewer, we have analyzed vesicle docking using SUVs, containing either VAMP2 or Syt1 or a combination of both proteins. The results shown in the new Figure 6 demonstrate that synaptotagmin1 is indeed the predominant docking factor. We agree that docked vesicles observed in our reconstituted assays and the 'readily releasable pool' may not be equivalent and have removed 'readily releasable pool' from the main text.
The paper uses several synaptotagmin mutants without looking at their biochemical effects in their system. What actually binds to what under their experimental conditions, and how does this change as a function of calcium?
We have now analyzed the docking of SUVs containing either VAMP2, or Syt1 (including Syt1 mutants) or both proteins by a sedimentation assay, which measures the binding of radiolabeled SUVs to t-SNARE GUVs (new Figure 6) . SUVs (7.5 nmol lipid, 9.4 pmol Syt1 or 38 pmol VAMP2) labeled with 3 H-DPPC were mixed with GUVs (42 nmol lipid, 0.84 nmol PI(4,5)P2, 42 pmol t-SNARE) in a final volume of 200 µl in the absence or presence of 20 µM Ca 2+ and incubated on ice for 5 min to allow docking. A Ca 2+ concentration of 20 µM was used (instead of 100 µM) because at this Ca 2+ concentration the Syt1wt and the Ca 2+ -binding mutant showed the most pronounced difference in the fusion assay. Subsequently, GUVs were sedimented for 5 min at 5000 g, 4 °C, and the fraction of bound 3 H-labeled SUVs in the pellet was determined. Counts obtained from control incubations containing protein-free SUVs were subtracted from individual measurement sets. Quantification of bound SUVs is normalized to 100% SUV input. Figure 6 shows that in the absence or presence of Ca 2+ , 60-85% of SUVs containing VAMP2/Syt1wt, Syt1 wt, or Syt1 D303/304N bind to t-SNARE GUVs. By contrast, in the absence of Ca 2+ , SUVs containing the polybasic mutant in the C2B domain of Syt1 (K326, 327, 331Q) or VAMP2-SUVs lacking Syt1, almost completely fail to bind to t-SNARE GUVs. Error bars SEM (n=3). Thus, under the conditions employed, v-and t-SNAREs are not sufficient to confer significant vesicle docking. Vesicle docking requires Syt1 and is dependent on the polybasic motif in the Syt1 C2B domain, consistent with previous publications. The SUV docking deficiency of the Syt1 C2B polybasic motif mutant can be partially rescued in the presence of Ca 2+ , likely via Ca 2+ -dependent interactions with anionic lipids or the t-SNARE, as shown in previous publications (Schiavo, et al. 1996 , Proc Natl Acad Sci USA, Zhang et al. 2002, Neuron; Bai et al. 2004, Neuron; Conell et al. 2008, L Mol Biol; Hui et al. 2011, Nat Struct Mol Biol ) . Taken together, the data of this sedimentation analysis correlates perfectly with the results obtained from the cryo-EM studies (Syt1 wt/VAMP2-SUVs, and VAMP2-SUVs).
The time resolution of the experiments is too low to allow conclusions about how similar the speed of the fusion reaction is to that observed in vivo. Moreover like all currently available in vitro fusion systems the calcium dependence of in vitro fusion indicates a much lower calcium affinity than synaptic vesicle fusion in vitro.
We are aware of the technical limitation of this in vitro fusion assay regarding the low temporal resolution and have mentioned this in the text. We do not directly compare the speed of the in vitro-and in vivo fusion reactions and acknowledge the advantage of imaging techniques using supported lipid bilayers and in vitro single vesicle fusion assays, which offer higher temporal resolution. Nevertheless, the GUV-SUV fusion assay combines the physiological properties of a low curvature t-SNARE membrane with the free diffusion of lipids and proteins, excluding potential limitations of supported bilayers. In future experiments we plan to include advanced imaging techniques and to adapt our assay accordingly.
We do not agree that the Ca 2+ concentration required to trigger fusion in the in vitro assay presented here is much higher than the Ca 2+ concentration required to trigger fusion of synaptic vesicles in vivo. We already observe a stimulation of lipid mixing at 2 µM Ca 2+ and robust stimulation occurs at Ca 2+ concentrations above 20 µM. A study by Heidelberger and colleagues (Heidelberger et al. 1994, Nature) reports that a given synaptic vesicle in the synaptic terminal of goldfish retinal bipolar neurons can exocytose with high probability within a few hundred microseconds, if the Ca 2+ concentration rises above 100 µM. In chromaffin cells, the readily releasable pool of vesicles, which appears to be Syt1-dependent, can be released by Ca 2+ concentration of 20-30 µM Ca 2+ (Voets et al., 2001, PNAS) . In pituitary cells, it has been reported that Syt1 increases the probability of vesicle fusion at low (µM) Ca 2+ concentrations (Kreft et al., 2002, Am J Cell Physiol) . Although many of these exocytosis events have been assigned to Syt1, the presence of other synaptotagmin isoforms might add further complexity in vivo. In vivo, local Ca 2+ microdomains and distances between the Ca 2+ sensor and Ca 2+ channels also determine the release probability of exocytosis (Rozov et al, 2001 , Journal of Physiology). Overall, taking into account these parameters, it seems not to be an overstatement to say that our in vitro data are in the range of Ca 2+ concentrations reported for Syt1-dependent exocytosis in vivo.
Reviewer 3:
The main problem with the manuscript is its very strong tone, which I believe it is not justified by the data presented even though I do consider the data very interesting.
We agree with the reviewer that an in vitro assays apparently cannot completely resemble the complexity of the in vivo situation, and that an extended set of components will be required to establish the complete mechanism, a concern that reviewer 2 has raised as well. In the revised manuscript, we have reworded critical text passages and tried to remove potential overstatements. The Drosophila orthologue of the Syt1 D303/309N mutant (abbreviated as syt B-D3,4N ), when expressed in a Syt1 null background in Drosophila leads to a complete loss of synchronized neurotransmitter release in neuromuscular junctions and a rightward shift in the Ca 2+ dose response curve, indicating that the apparent Ca 2+ affinity is reduced in this mutant (Mackler et al., 2002, Nature) . In contrast to the syt B-D3,4N mutant, the syt B-D1,2N mutant, which affects the other two aspartate residues coordinating Ca 2+ binding in the C2B domain, is embryonic lethal (Mackler et al. 2002, Nature) . This observation illustrates that the syt B-D3,4N mutant still has some residual activity. However, raising the extracellular Ca 2+ concentration from 2 to 5 mM does not rescue the severe inhibition of exocytosis in the syt B-D3,4N mutant. In the liposome fusion assay, the Syt1 D303/309N mutant is severely impaired in triggering lipid mixing by Ca 2+ when compared to Syt1 wt. While 2 µM Ca 2+ are already sufficient to cause a significant fusion signal of Syt1 wt, Ca 2+ concentrations of 50-100 µM are required to obtain a similar signal in the presence of the Syt1 D303/309N mutant. For effective fusion, 1 mM Ca 2+ needs to be added to this Syt1 mutant in the in vitro reaction. We agree with the reviewer that a Ca 2+ concentration of 1 mM is sufficient to completely rescue efficient fusion of the Syt1 mutant in vitro, while extracellular Ca 2+ concentrations up to 5 mM do not rescue fusion in vivo. However, a direct comparison of the in vitro and in vivo results may be difficult, because, according to our knowledge, the effective increase of the local intracellular Ca 2+ concentration that results from increasing the extracellular Ca 2+ concentration is not known. We changed the discussion accordingly. Concerning the Syt1 C2B domain polybasic motif, the mutant shows a relatively mild phenotype in vivo (55% reduction in the amplitude of excitatory junctional potentials (EJPs) in Drosophila synaptotagmin null third instars that express the C2B-polylysine motif transgene) (Loewen et al. 2006, Mol Biol Cell) . Likewise, in the presence of CpxII, the fast Ca 2+ -dependent stimulation in the liposome fusion assay is reduced by approximately 60% (see Figure 5) , which correlates well with the in vivo reduction of evoked release. (The electrophysiological studies in Drosophila were performed in a complexin wt background.) We have already addressed these issues in the discussion section 'Tight functional coupling of Syt1 and Cpx'.
B. It is true that the authors observe inhibitory and stimulatory effects of complexin in this system
, and this correlates qualitatively with in vivo data. However, the proteins they are using are mammalian, and in mammals the stimulatory effect of complexin is quite more substantial than the inhibitory effect, in contrast to what the authors observe in the lipid mixing assays.
We agree that the role of complexins in the mammalian system is still controversial, and system-dependent differences can be observed. For example, neuronal autapses derived from Cpx knock out mice do not show an increase of spontaneous release events (Xue et al. 2008, PNAS) . In contrast, knockdown of CpxI and CpxII in cultured cortical neurons using short hairpin RNA (shRNA) increased the frequency of spontaneous miniature postsynaptic currents 3-4-fold (Maximov et al. 2009, Science) . Thus, also the mammalian Cpx suppresses spontaneous release events indicating that Cpxs in vertebrate and invertebrates have fundamentally the same function. Variations of the Cpx phenotype observed in vivo seem to depend to some degree on the cellular system and/or the method applied. A detailed discussion of this issue would be largely speculative and beyond the scope of this manuscript.
C. Physiologically, Munc18-1 and Munc13s play crucial roles in neurotransmitter release but they are not present in these assays.
As correctly pointed out by reviewer, Munc18-1, Munc13, and many other components functioning earlier in vesicle tethering are still missing in our assay. We will make all possible efforts to overcome these shortcomings in our future experiments. The paper by deWit and colleagues 2009 (Cell) shows that the docking function of Munc18-1 can be bypassed by the overexpression of SNAP-25 indicating that preassembled t-SNARE complexes are the molecular target for synaptotagmin 1-mediated vesicle docking. Our in vitro assay is based on the reconstitution of preassembled t-SNAREs and thus we intentionally bypassed earlier functions of Munc18-1. We now mention the roles of Munc13 and Munc18 in docking and priming in the last sentence of the discussion. We acknowledge that the liposome fusion assay in fact measures lipid mixing and not content mixing and have exchanged the word 'fusion' by 'lipid mixing' when referring to data from plate reader-derived measurements. Nevertheless, our cryo-EM studies strongly suggest that we observe full membrane fusion (see comments below). Figure 2D to claim that they observe fusion, but these data really cannot distinguish between real fusion and bursting of membranes followed by reannealing.
There is a big tendency in this field

The authors also use the cryo-EM data of
Although not formally proven, we consider it extremely unlikely that the docked vesicles fuse unspecifically by a bursting process. This scenario would imply that bursting and reannealing is consistent between preparations, and follows well defined Ca 2+ , Cpx and Syt dependencies. Further, in the lipid mixing assay, we show specific requirements for the major components of the fusion machinery, known to mediate calcium regulated exocytosis in vivo and included appropriate controls.
The authors should clarify why they count SUV clusters on the GUVs rather than just SUVs on the
GUVs to obtain the data of Figure 2B .
We have now counted individual SUVs (see response to reviewer 1).
In the top of page 8, the authors state that control samples treated with neurotoxin did not show any increase in NBD fluorescence, but then they state that the background of these control samples was subtracted. I do not understand why they subtract the background if the increase was zero.
The NBD fluorescence of BoNTD treated control samples decreases slowly and in a linear fashion over the entire length of the measurement, which is due to photo bleaching. Hence, we subtracted the corresponding values to compensate for this loss of NBD fluorescence. In addition, the subtraction of the BoNTD control corrects for small dilution effects caused by the addition of Ca 2+ .
6. In page 10, the authors mention the Ca 2+ concentration required for synaptotagmin-1 binding to lipids (from Hui et al., 2005) 
